Contrast Media Injector Market 2021 Forecast
The global market for contrast media power injector is set to increase from $945 million in 2016 to almost $2.0 billion by 2024, according to research and consulting firm McKesson. This represents a compound annual growth rate (CAGR) of 12 percent.
The reason for the fast growth, according to this article, is driven by the fast-growing number of annual computed tomography (CT), magnetic resonance imaging (MRI) and angiography procedures. Power injectors can only be used alongside imaging devices, so the power injector market relies on the growing demand for CT and MRI scanners.
ANTMED is the leading domestic manufacturer in contrast imaging industry and the only one-stop solution supplier of CT, MRI and DSA contrast media power injectors, Medical injection systems and disposables in China. ANTMED provides complete suite of CT Single, CT Dual, Ceiling Mount, MR and Angio contrast power injectors such as Bayer Medrad, Guerbet LF, Nemoto, Medtron, EZEM,CT. Our injector has been sold to more than 70 countries in the world.
Compared with 2019, Antmed ImaStar Dual-head injector has experienced high growth in Asia as hospitals seek to upgrade their injectors with more efficient models for lower costs. Asia Pacific is expected to grow at the highest CAGR during 2021, primarily due to factors such as rising aging population and cancer incidence in Japan, increasing R&D investments and favorable demographic scenario in China, and growing investment in the Indian radiology market are driving the growth of this regional segment. Africa is also a new growth point. Right now our top selling product is dual-head injector. The second ranking is the single head injector because their low average selling price.
About Antmed
ANTMED provides complete suite of CT Single, CT Dual, Ceiling Mount, MR and Angio contrast power injectors. As an innovator in diagnostic and interventional radiology products, Antmed utilizes cutting edge technologies in our product design and manufacturing methodology. The Antmed ImaStar Series of contrast injectors is installed in more than 1,000 hospitals in China and a growing international market of more than 100 countries. ImaStar series is a complete line that includes CT single-head, CT dual-head, DSA and MR injectors with pedestal, ceiling mount and table mount options. We will keep on working with our dealers and develop more flagship hospitals to expand domestic and global market. If you are interested in learning more about our contrast power injector, please contact us at: info@antmed.com.
Post time: Jan-21-2021